{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010/schedule/rule-3",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010/schedule/rule-3.json",
  "legislation": "uksi/2010/1616",
  "legislation_title": "The General Pharmaceutical Council (Statutory Committees and their Advisers Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-statutory-committees-and-their-advisers-rules-order-of-council-2010",
  "path": "schedule/rule/3",
  "kind": "rule",
  "number": "3",
  "heading": "Composition of the statutory committees",
  "text": "(1) The Investigating Committee is to consist of—\n(a) a lay member who is the chair;\n(b) two lay members who are deputy chairs; and\n(c) not fewer than three and not more than eleven other members who may be lay members or registrant members.\n(d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(2) The Fitness to Practise Committee is to consist of—\n(a) a lay member who is the chair;\n(b) not fewer than three and not more than eight lay members who are deputy chairs; and\n(c) not fewer than eight and not more than fifty one other members who may be lay members or registrant members.\n(d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(3) The Appeals Committee is to consist of—\n(a) a lay member who is the chair;\n(b) two lay members who are deputy chairs; and\n(c) not fewer than three and not more than seventeen other members who may be lay members or registrant members.\n(d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(3A) The number of lay members of each committee (including any chair or deputy chair) must be at least the same as the number of registrant members.\n(4) The chairs and deputy chairs referred to in paragraphs (1)(a) and (b), (2)(a) and (b) and (3)(a) and (b) may be legally qualified.\n(5) In the absence of the chair of a statutory committee at a meeting or hearing, one of the deputy chairs of that committee may perform the functions of the chair.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Word in Sch. rule 3(1)(b) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(2)(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Sch. rule 3(1)(c) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(2)(b)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Sch. rule 3(1)(d) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(2)(c)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Sch. rule 3(2)(b) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(3)(a)"
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Sch. rule 3(2)(c) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(3)(b)"
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Sch. rule 3(2)(d) omitted (5.2.2013) by virtue of The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(3)(c)"
    },
    {
      "type": "F",
      "label": "F7",
      "text": "Word in Sch. rule 3(3)(b) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(4)(a)"
    },
    {
      "type": "F",
      "label": "F8",
      "text": "Sch. rule 3(3)(c) substituted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(4)(b)"
    },
    {
      "type": "F",
      "label": "F9",
      "text": "Sch. rule 3(3)(d) repealed (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(4)(c)"
    },
    {
      "type": "F",
      "label": "F10",
      "text": "Sch. rule 3(3A) inserted (5.2.2013) by The General Pharmaceutical Council (Amendment of Miscellaneous Provisions) Rules Order of Council 2012 (S.I. 2012/3171), Sch. rules 2, 4(5)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 3 in force at 27.9.2010, see Sch. rule 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1616/schedule/rule/3",
    "retrieved_at": "2026-11-06T03:38:08.493928+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}